CDK9-IN-36 (Compound T7) is a potent, selective, and metabolically stable CDK9 inhibitor with an IC50 value of 1.2 nM. It effectively suppresses the proliferation of Osimertinib-resistant NSCLC cells by downregulating Mcl-1, reducing colony formation, and inducing apoptosis. Additionally, CDK9-IN-36 exhibits antitumor activity in xenograft models.
Molecular Weight:
565.61
Formula:
C30H33F2N5O4
Target:
CDK|||Apoptosis
* VAT and and shipping costs not included. Errors and price changes excepted
